Literature DB >> 7899230

The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.

W J Irwin1, A K Dwivedi, P A Holbrook, M J Dey.   

Abstract

Leucine enkephalin (YGGFL) undergoes rapid degradation in sheep nasal mucosa to yield GGFL which is further degraded to FL. The activity of the nasal mucosal homogenate against YGGFL and GGFL (t1/2 12 and 7 min) was significantly greater than that observed with a nasal wash fluid (t1/2 40 and 13 min). The effect of cyclodextrins on the rate of degradation of FGG and YGGFL by leucine aminopeptidase (LAP) and of GGF by carboxypeptidase A (CPA) was monitored. Little effect was observed with FGG (with LAP) but the half-life of YGGFL (with LAP) was extended from approximately 44 min to approximately 75 min in the presence of a 25-fold excess of beta-cyclodextrin. The stability of GGF (with CPA) was also enhanced; an effect was observable with a 5-fold excess of cyclodextrin and the half-life could be extended by 40-75%. An equation is presented which allows the estimation of the concentration of free peptide in the peptide-cyclodextrin solutions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899230     DOI: 10.1023/a:1018946829225

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

Review 1.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Inhibition of enkephalin-degrading aminopeptidase activity by certain peptides.

Authors:  R K Barclay; M A Phillipps
Journal:  Biochem Biophys Res Commun       Date:  1980-10-31       Impact factor: 3.575

4.  Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.

Authors:  N G Schipper; S G Romeijn; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

5.  Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli.

Authors:  R Matsas; I S Fulcher; A J Kenny; A J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

6.  Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.

Authors:  N G Schipper; J C Verhoef; L M De Lannoy; S G Romeijn; J H Brakkee; V M Wiegant; W H Gispen; F W Merkus
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.

Authors:  T Irie; M Otagiri; M Sunada; K Uekama; Y Ohtani; Y Yamada; Y Sugiyama
Journal:  J Pharmacobiodyn       Date:  1982-09

Review 8.  Cyclodextrins in drug carrier systems.

Authors:  K Uekama; M Otagiri
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

9.  Transmucosal delivery of leucine enkephalin: stabilization in rabbit enzyme extracts and enhancement of permeation through mucosae.

Authors:  A P Sayani; I K Chun; Y W Chien
Journal:  J Pharm Sci       Date:  1993-11       Impact factor: 3.534

10.  Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases.

Authors:  S D Kashi; V H Lee
Journal:  Life Sci       Date:  1986-06-02       Impact factor: 5.037

View more
  4 in total

1.  Protection afforded by maltosyl-beta-cyclodextrin against alpha-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate.

Authors:  K Matsubara; Y Ando; T Irie; K Uekama
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

2.  The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.

Authors:  W J Irwin; A K Dwivedi; P A Holbrook; M J Dey
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

3.  Iron Oxide Nanoparticle Delivery of Peptides to the Brain: Reversal of Anxiety during Drug Withdrawal.

Authors:  Nathan Vinzant; Jamie L Scholl; Chia-Ming Wu; Trevor Kindle; Ranjit Koodali; Gina L Forster
Journal:  Front Neurosci       Date:  2017-11-01       Impact factor: 4.677

Review 4.  Nasal delivery of high molecular weight drugs.

Authors:  Yildiz Ozsoy; Sevgi Gungor; Erdal Cevher
Journal:  Molecules       Date:  2009-09-23       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.